Xeris Biopharma (XERS) Financials: Revenue & Earnings

XERS$16.80—
BiotechnologyGrowth StockHigh Quality
Compare
Market cap$3.10BEnterprise value—Revenue (TTM)$368.26MMarket position—

Score

65
Bullish
Value
32
Quality
70
Growth
94

Financial Summary

Xeris Biopharma Holdings, Inc. (XERS) last printed $16.80. Equity value is $3.10B. Trailing earnings multiple —. The revenue row is reported history.

Financials

2016201720182019202020212022202320242025
$1.07M$1.56M$2.46M$2.72M$20.43M$49.59M$110.25M$163.91M$203.07M$291.85M

Xeris Biopharma (XERS) Financials: Revenue & Earnings

XERS price $16.80 —

Ticker
XERS
Price
$16.80
Change
—
Market cap
$3.10B
Forward P/E
42.07
Dividend yield
0.00%
Beta
0.84
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
65
Value
32
Quality
70
Growth
94

Stocklytics score rationale: value 32, quality 70, growth 94.

Insights · Forecast · Financials · Learn

Stocklytics home · Screener